Table of contents

Method: FDA-cleared clinical laboratory assay performed in CLIA-certified, CAP-accredited laboratories. Used to aid clinician-directed evaluation and monitoring. Not a stand-alone diagnosis.

ALP is an enzyme that is found in various tissues, mainly in the liver and bone.

Similar biomarker tests from Superpower

FAQs about Alkaline Phosphatase (ALP) Test

Alkaline phosphatase (ALP) is an enzyme made mostly in the liver and bones, with smaller contributions from the intestines, kidneys, and (in pregnancy) the placenta. ALP helps remove phosphate groups from molecules, supporting essential processes like bone mineralization and normal bile flow in the liver. Because ALP enters the bloodstream during routine tissue activity and turnover, a blood test can act as a broad signal of liver and bone function.

An ALP test offers a “window” into how actively your liver and bones are working right now. High ALP can be an early clue to bile duct blockage, inflammation, fatty liver disease, or hepatitis, and it can also reflect increased bone turnover from growth, fracture healing, or bone disorders. Low ALP, although less common, may suggest nutrient deficiencies or reduced bone formation. Results are most useful when interpreted alongside symptoms.

Normal adult ALP values are typically in a broad reference range (often roughly the 40s to the 140s, depending on the lab). “Optimal” levels generally sit comfortably in the middle of that span, reflecting balanced liver bile flow and steady bone remodeling. However, ALP naturally varies by age and life stage - children and teens often run much higher during growth spurts, and pregnancy can raise ALP due to placental production.

High ALP most commonly points to either increased bone activity or impaired bile flow (cholestasis). Bone-related causes include growth spurts, fracture healing, Paget’s disease, and sometimes bone metastases. Liver-related causes include blocked bile ducts, gallstones, fatty liver disease, hepatitis, inflammation, infiltrative disease, or medication effects. ALP can also rise in the third trimester of pregnancy and may increase mildly after menopause due to bone remodeling.

Low ALP is uncommon but can reflect reduced bone turnover, malnutrition, or deficiencies in key nutrients such as zinc, magnesium, or protein. It may be seen with celiac disease, hypothyroidism, severe anemia, or after major surgery when the body is under metabolic stress. In rare cases, persistently low ALP can be linked to hypophosphatasia, a genetic condition that affects bone and tooth mineralization from childhood onward.

Because ALP is produced in multiple tissues, clinicians look at the overall pattern and often pair ALP with related markers to identify the source. The context highlights interpreting ALP with tests like GGT and bilirubin (more suggestive of liver/bile duct issues) and calcium (more informative for bone metabolism), along with your symptoms. When uncertainty remains, ALP isoenzyme testing or imaging may be used to distinguish bone versus liver sources.

ALP becomes more specific when combined with other labs that “point” to the organ system involved. Higher ALP with elevated GGT and bilirubin often supports a liver or bile-duct (cholestatic) pattern, while ALP changes alongside calcium can add context for bone turnover and mineral balance. This combined interpretation helps clinicians evaluate fatigue, abdominal discomfort, or bone pain more accurately and guide next steps such as additional labs or imaging.

ALP often rises when bone formation is high. Children and adolescents can have ALP levels two to four times adult values during growth phases because their skeleton is rapidly building and mineralizing. Similarly, ALP can increase during fracture healing as bone remodeling accelerates to repair the injury. These increases can be normal in the right context, but persistent or very high results may still warrant evaluation for bone disorders.

Yes. Pregnancy commonly increases ALP - especially in the third trimester - because the placenta produces its own ALP isoenzyme that enters the bloodstream. After menopause, some women experience mild ALP increases due to changes in bone remodeling and turnover. Because these life-stage effects can be normal, clinicians typically interpret ALP using pregnancy status, age, symptoms, and companion labs (such as bilirubin, GGT, and calcium) to avoid unnecessary alarm.

ALP can shift due to non-disease factors, which is why context matters. The page notes age and sex differences, pregnancy-related rises, and post-meal (postprandial) increases in some people with blood type O. Certain medications - such as antibiotics and anticonvulsants - can elevate ALP. Because ALP can come from different tissues, clinicians may use isoenzyme testing or imaging when results don’t match symptoms or other lab markers.